San Diego, CA 4/4/2009 12:54:36 AM
News / Finance

Small Cap Network Publishes Op-Ed Article on Biotech M&A Outlook Following MRK, PFE, GILD Deals

Recent Biopharma Mergers May Not Necessarily Be a Sign of What's to Come

The editor of the Small Cap Network (smallcapnetwork.com), a leading online investment community focused on small cap stocks, today published a cautionary op-ed commentary regarding recent speculation of mergers and acquisitions within the biopharma and biotech industry. The column “Biotech Secretly Stinks – We’ve Been Duped” explains why recent mergers of Merck (MRK) with Schering-Plough (SGP) and Pfizer (PFE) with Wyeth (WYE) may not actually be an omen of more follow-up M&A activity.   

Investors can receive complete access to all trading commentary and market trend analysis free by going to: www.smallcapnetwork.com/t/

Speculation of biotech stock buyouts has been growing since March, fueled by Pfizer, Merck, Roche, Gilead Sciences (GILD), and others all striking some of the industry’s all-time largest merger deals. However, there are also some trends and data most investors should be aware of before jumping to any conclusions about further M&A within the biotech arena. The op-ed column begins a dialog around that information.


Investors and traders are invited to subscribe to the free Small Cap Network Newsletter, which offers other trading ideas and insights at:www.smallcapnetwork.com/t/

About SmallCapNetwork

SmallCapNetwork.com's commentary and trading ideas are based on a combination of fundamental analysis, company news and events, and technical analysis. This combination of several kinds of criteria allows the site's analysts to find the very best trading ideas, which is why the site is quickly becoming the premier web destination for those seeking superior returns.

The Small Cap Network is one of the web's leading small cap stock trading communities. Though large caps tend to receive the majority of media attention, small and micro cap stocks as well as penny stocks can often offer the most potential for investment gains. The Small Cap Network web site and free newsletter offer in-depth fundamental research and technical trading recommendations on select companies within the global equity markets, including small and micro cap stocks, bulletin board stocks, and actively traded penny stocks. Biotech merger and acquisition trends are going to be one of the site’s focal points for the foreseeable future.

Forward-Looking Statement: This press release may include or imply "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

SmallCapNetwork.com is not a registered investment advisers or broker/dealer. SmallCapNetwork.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for many of their securities, investing in such securities is highly speculative and carries a high degree of risk. 

Contact Information:
Small Cap Network
4653 Carmel Mtn. Rd Suite 308 #402 
San Diego, CA 92130

Email: editor@smallcapnetwork.com

Source: Small Cap Network